Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up
Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%. However, the occurrence of a late thrombosis can compromise long-term results, particularly if the risks of this event were sustained. In this context, a registry of clinical cases gains special value. Objective: To evaluate the efficacy and safety of drug-eluting stents in the real world. Methods: We report on the clinical findings and 8-year follow-up parameters of all patients that underwent percutaneous coronary intervention with a drug-eluting stent from January 2002 to April 2007. Drug-eluting stents were used in accordance with the clinical and interventional cardiologist decision and availability of the stent. Results: A total of 611 patients were included, and clinical follow-up of up to 8 years was obtained for 96.2% of the patients. Total mortality was 8.7% and nonfatal infarctions occurred in 4.3% of the cases. Target vessel revascularization occurred in 12.4% of the cases, and target lesion revascularization occurred in 8% of the cases. The rate of stent thrombosis was 2.1%. There were no new episodes of stent thrombosis after the fifth year of follow-up. Comparative subanalysis showed no outcome differences between the different types of stents used, including Cypher®, Taxus®, and Endeavor®. Conclusion: These findings indicate that drug-eluting stents remain safe and effective at very long-term follow-up. Patients in the "real world" may benefit from drug-eluting stenting with excellent, long-term results.
Main Authors: | , , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia - SBC
2014
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2014002100002 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0066-782X2014002100002 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0066-782X20140021000022014-10-21Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-UpPellegrini,Denise OliveiraGomes,Vitor OsórioLasevitch,RicardoSmidt,LuisAzeredo,Marco AurélioLedur,PriscilaBodanese,RodrigoSinnott,LeonardoMoriguchi,EmílioCaramori,Paulo Drug-Eluting Stents/trends Treatment Outcome Effectiveness Long-Term Effect Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%. However, the occurrence of a late thrombosis can compromise long-term results, particularly if the risks of this event were sustained. In this context, a registry of clinical cases gains special value. Objective: To evaluate the efficacy and safety of drug-eluting stents in the real world. Methods: We report on the clinical findings and 8-year follow-up parameters of all patients that underwent percutaneous coronary intervention with a drug-eluting stent from January 2002 to April 2007. Drug-eluting stents were used in accordance with the clinical and interventional cardiologist decision and availability of the stent. Results: A total of 611 patients were included, and clinical follow-up of up to 8 years was obtained for 96.2% of the patients. Total mortality was 8.7% and nonfatal infarctions occurred in 4.3% of the cases. Target vessel revascularization occurred in 12.4% of the cases, and target lesion revascularization occurred in 8% of the cases. The rate of stent thrombosis was 2.1%. There were no new episodes of stent thrombosis after the fifth year of follow-up. Comparative subanalysis showed no outcome differences between the different types of stents used, including Cypher®, Taxus®, and Endeavor®. Conclusion: These findings indicate that drug-eluting stents remain safe and effective at very long-term follow-up. Patients in the "real world" may benefit from drug-eluting stenting with excellent, long-term results. info:eu-repo/semantics/openAccessSociedade Brasileira de Cardiologia - SBCArquivos Brasileiros de Cardiologia v.103 n.3 20142014-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2014002100002en10.5935/abc.20140110 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Pellegrini,Denise Oliveira Gomes,Vitor Osório Lasevitch,Ricardo Smidt,Luis Azeredo,Marco Aurélio Ledur,Priscila Bodanese,Rodrigo Sinnott,Leonardo Moriguchi,Emílio Caramori,Paulo |
spellingShingle |
Pellegrini,Denise Oliveira Gomes,Vitor Osório Lasevitch,Ricardo Smidt,Luis Azeredo,Marco Aurélio Ledur,Priscila Bodanese,Rodrigo Sinnott,Leonardo Moriguchi,Emílio Caramori,Paulo Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up |
author_facet |
Pellegrini,Denise Oliveira Gomes,Vitor Osório Lasevitch,Ricardo Smidt,Luis Azeredo,Marco Aurélio Ledur,Priscila Bodanese,Rodrigo Sinnott,Leonardo Moriguchi,Emílio Caramori,Paulo |
author_sort |
Pellegrini,Denise Oliveira |
title |
Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up |
title_short |
Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up |
title_full |
Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up |
title_fullStr |
Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up |
title_full_unstemmed |
Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up |
title_sort |
efficacy and safety of drug-eluting stents in the real world: 8-year follow-up |
description |
Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%. However, the occurrence of a late thrombosis can compromise long-term results, particularly if the risks of this event were sustained. In this context, a registry of clinical cases gains special value. Objective: To evaluate the efficacy and safety of drug-eluting stents in the real world. Methods: We report on the clinical findings and 8-year follow-up parameters of all patients that underwent percutaneous coronary intervention with a drug-eluting stent from January 2002 to April 2007. Drug-eluting stents were used in accordance with the clinical and interventional cardiologist decision and availability of the stent. Results: A total of 611 patients were included, and clinical follow-up of up to 8 years was obtained for 96.2% of the patients. Total mortality was 8.7% and nonfatal infarctions occurred in 4.3% of the cases. Target vessel revascularization occurred in 12.4% of the cases, and target lesion revascularization occurred in 8% of the cases. The rate of stent thrombosis was 2.1%. There were no new episodes of stent thrombosis after the fifth year of follow-up. Comparative subanalysis showed no outcome differences between the different types of stents used, including Cypher®, Taxus®, and Endeavor®. Conclusion: These findings indicate that drug-eluting stents remain safe and effective at very long-term follow-up. Patients in the "real world" may benefit from drug-eluting stenting with excellent, long-term results. |
publisher |
Sociedade Brasileira de Cardiologia - SBC |
publishDate |
2014 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2014002100002 |
work_keys_str_mv |
AT pellegrinideniseoliveira efficacyandsafetyofdrugelutingstentsintherealworld8yearfollowup AT gomesvitorosorio efficacyandsafetyofdrugelutingstentsintherealworld8yearfollowup AT lasevitchricardo efficacyandsafetyofdrugelutingstentsintherealworld8yearfollowup AT smidtluis efficacyandsafetyofdrugelutingstentsintherealworld8yearfollowup AT azeredomarcoaurelio efficacyandsafetyofdrugelutingstentsintherealworld8yearfollowup AT ledurpriscila efficacyandsafetyofdrugelutingstentsintherealworld8yearfollowup AT bodaneserodrigo efficacyandsafetyofdrugelutingstentsintherealworld8yearfollowup AT sinnottleonardo efficacyandsafetyofdrugelutingstentsintherealworld8yearfollowup AT moriguchiemilio efficacyandsafetyofdrugelutingstentsintherealworld8yearfollowup AT caramoripaulo efficacyandsafetyofdrugelutingstentsintherealworld8yearfollowup |
_version_ |
1756381941941141504 |